AT340610B - Verfahren zur herstellung von neuenprostanoesaurederivaten und von ihren basenadditionssalzen - Google Patents

Verfahren zur herstellung von neuenprostanoesaurederivaten und von ihren basenadditionssalzen

Info

Publication number
AT340610B
AT340610B AT832673A AT832673A AT340610B AT 340610 B AT340610 B AT 340610B AT 832673 A AT832673 A AT 832673A AT 832673 A AT832673 A AT 832673A AT 340610 B AT340610 B AT 340610B
Authority
AT
Austria
Prior art keywords
preparation
addition salts
acid derivatives
base addition
prostanoic acid
Prior art date
Application number
AT832673A
Other languages
English (en)
Other versions
ATA832673A (de
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to AT123975A priority Critical patent/AT341123B/de
Priority to AT124075A priority patent/AT342217B/de
Priority to AT124175A priority patent/AT342218B/de
Priority to AT123775A priority patent/AT341121B/de
Priority to AT123875A priority patent/AT341122B/de
Publication of ATA832673A publication Critical patent/ATA832673A/de
Application granted granted Critical
Publication of AT340610B publication Critical patent/AT340610B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
AT832673A 1972-09-27 1973-09-27 Verfahren zur herstellung von neuenprostanoesaurederivaten und von ihren basenadditionssalzen AT340610B (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AT123975A AT341123B (de) 1972-09-27 1975-02-19 Verfahren zur herstellung von neuen prostanoesaurederivaten
AT124075A AT342217B (de) 1972-09-27 1975-02-19 Verfahren zur herstellung von neuen prostanoesaurederivaten
AT124175A AT342218B (de) 1972-09-27 1975-02-19 Verfahren zur herstellung von neuen prostanoesaurederivaten und von ihren basenadditionssalzen
AT123775A AT341121B (de) 1972-09-27 1975-02-19 Verfahren zur herstellung von neuen prostanoesaurederivaten und von ihren basenadditionssalzen
AT123875A AT341122B (de) 1972-09-27 1975-02-19 Verfahren zur herstellung von neuen prostanoesaurederivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4465272A GB1428137A (en) 1972-09-27 1972-09-27 Prostanoic acid derivatives

Publications (2)

Publication Number Publication Date
ATA832673A ATA832673A (de) 1977-04-15
AT340610B true AT340610B (de) 1977-12-27

Family

ID=10434217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT832673A AT340610B (de) 1972-09-27 1973-09-27 Verfahren zur herstellung von neuenprostanoesaurederivaten und von ihren basenadditionssalzen

Country Status (25)

Country Link
US (1) US3931206A (de)
JP (1) JPS49100071A (de)
AR (1) AR207550A1 (de)
AT (1) AT340610B (de)
BE (1) BE805358A (de)
CA (1) CA1037033A (de)
CH (3) CH597175A5 (de)
CS (3) CS178895B2 (de)
DD (1) DD107899A5 (de)
DE (1) DE2348632A1 (de)
EG (1) EG11278A (de)
ES (5) ES419143A1 (de)
FR (1) FR2200014B1 (de)
GB (1) GB1428137A (de)
HU (1) HU171777B (de)
IE (1) IE38241B1 (de)
IL (1) IL43248A (de)
NL (1) NL7313322A (de)
NO (1) NO145380C (de)
PL (2) PL97363B1 (de)
SE (3) SE424859B (de)
SU (1) SU648088A3 (de)
YU (2) YU254573A (de)
ZA (1) ZA737357B (de)
ZM (1) ZM15873A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3953502A (en) 1973-01-31 1976-04-27 Imperial Chemical Industries Limited Cyclopentane derivatives
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
DE2524955C3 (de) 1975-06-05 1981-12-03 Hoechst Ag, 6000 Frankfurt Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
AU6691798A (en) * 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
US6284748B1 (en) * 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
JP2001515482A (ja) * 1997-03-07 2001-09-18 メタバシス・セラピューティクス・インコーポレイテッド フルクトース−１，６−ビスホスファターゼの新規なベンズイミダゾールインヒビター
WO2000014095A1 (en) * 1998-09-09 2000-03-16 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
NZ513825A (en) * 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US6965033B2 (en) * 1999-12-22 2005-11-15 Metabasis Therapeutics, Inc. Bisamidate phosphonate prodrugs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7563774B2 (en) * 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
CN101005847A (zh) * 2004-08-18 2007-07-25 症变治疗公司 果糖1,6－双磷酸酶的新颖噻唑类抑制剂
CN113912539B (zh) * 2021-12-13 2022-03-11 山东国邦药业有限公司 一种环丙羧酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
US3726909A (en) * 1970-10-16 1973-04-10 P Beal 9,15-dihydroxy prostanoic acids and esters thereof

Also Published As

Publication number Publication date
NO145380C (no) 1982-03-10
CH596164A5 (de) 1978-02-28
CS178894B2 (en) 1977-10-31
FR2200014A1 (de) 1974-04-19
JPS49100071A (de) 1974-09-20
SE424859B (sv) 1982-08-16
CS178895B2 (en) 1977-10-31
DD107899A5 (de) 1974-08-20
GB1428137A (en) 1976-03-17
SE7611316L (sv) 1976-10-12
FR2200014B1 (de) 1978-01-13
CH597175A5 (de) 1978-03-31
ES419143A1 (es) 1976-06-16
EG11278A (en) 1977-08-15
AR207550A1 (es) 1976-10-15
CA1037033A (en) 1978-08-22
HU171777B (hu) 1978-03-28
IE38241L (en) 1975-03-12
ES444045A1 (es) 1977-04-16
ES444044A1 (es) 1977-04-16
US3931206A (en) 1976-01-06
SU648088A3 (ru) 1979-02-15
CH595341A5 (de) 1978-02-15
DE2348632A1 (de) 1974-04-11
PL97363B1 (pl) 1978-02-28
IL43248A (en) 1977-08-31
ATA832673A (de) 1977-04-15
ES444047A1 (es) 1977-04-16
CS178893B2 (en) 1977-10-31
YU254573A (en) 1982-02-28
ZA737357B (en) 1974-08-28
NO145380B (no) 1981-11-30
ZM15873A1 (en) 1975-05-21
IL43248A0 (en) 1973-11-28
PL96782B1 (pl) 1978-01-31
ES444046A1 (es) 1977-04-16
SE7611315L (sv) 1976-10-12
NL7313322A (de) 1974-03-29
IE38241B1 (en) 1978-02-01
BE805358A (fr) 1974-03-26
YU268580A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
AT321916B (de) Verfahren zur herstellung von neuen substituierten piperidinderivaten und ihren säureadditionssalzen
AT313270B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten und ihren Salzen
AT340610B (de) Verfahren zur herstellung von neuenprostanoesaurederivaten und von ihren basenadditionssalzen
AT304534B (de) Verfahren zur Herstellung von neuen Pyrazol-4-essigsäurederivaten und ihren Salzen
AT325034B (de) Verfahren zur herstellung von neuen benzofuranderivaten und ihren salzen
AT300793B (de) Verfahren zur Herstellung von neuen Thiazolylessigsäurederivaten und ihren Salzen
ATA987272A (de) Verfahren zur herstellung von neuen 9- (4-piperidyliden) -thioxanthenderivaten und ihren saureadditionssalzen
AT351538B (de) Verfahren zur herstellung von neuen hydratropasaeure-derivaten und ihren salzen
AT349004B (de) Verfahren zur herstellung von neuen 4- hydroxyindol-derivaten und ihren salzen
ATA96474A (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren salzen
AT338774B (de) Verfahren zur herstellung von 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-inden-3-essigsaure und ihren saureadditionssalzen
AT310742B (de) Verfahren zur Herstellung von neuen 2-Amino-4-phenyl-thiazolderivaten und ihren Salzen
AT325622B (de) Verfahren zur herstellung von neuen isoindolinonderivaten und ihren säureadditionssalzen
ATA46475A (de) Verfahren zur herstellung von neuen phentiazinderivaten und von ihren saureadditionssalzen
AT310731B (de) Verfahren zur Herstellung von neuen Indenopyrrolderivaten und ihren Salzen
AT303035B (de) Verfahren zur Herstellung von neuen basischen Phenyl-azolyl-fettsäurederivaten und ihren Salzen
AT315827B (de) Verfahren zur Herstellung von neuen 4-Chlor-5-sulfamoyl-anthranilsäurederivaten und ihren Salzen
AT305279B (de) Verfahren zur Herstellung von neuen Thiazolino-pyrimidin-5-on-derivaten und ihren Salzen
AT308088B (de) Verfahren zur Herstellung von neuen 2-Phenyliminopyrrolidinderivaten und ihren Salzen
AT319243B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Säureadditionssalzen
AT310165B (de) Verfahren zur Herstellung von neuen 4-Sulfamoyl-m-toluidin-Derivaten und ihren Salzen
AT308089B (de) Verfahren zur Herstellung von neuen Thienylalkanderivaten und ihren Salzen
AT329567B (de) Verfahren zur herstellung von neuen homopyrimidazolderivaten und ihren salzen
AT342218B (de) Verfahren zur herstellung von neuen prostanoesaurederivaten und von ihren basenadditionssalzen
ATA123775A (de) Verfahren zur herstellung von neuen prostanoesaurederivaten und von ihren basenadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee